Nektar Therapeutics (NASDAQ:NKTR) is one of the hot stocks to buy with huge upside potential. On October 22, Nektar ...
Nektar Therapeutics (Nasdaq: NKTR) announced today that new data from the ongoing REZOLVE-AD Phase 2b study of ...
MANNHEIM, Germany, April 23, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) ("Affimed”, or the "Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ...
The creative department of an advertising agency or in-house marketing department relies much more on facts and figures than concepts and slogans. The bottom-line goal of any advertising idea should ...
SAN DIEGO & TAICANG & SUZHOU, China--(BUSINESS WIRE)--Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing ...
All titles, abstracts, photos and YouTube presentations will need your research mentor’s approval prior to submitting your abstract. The abstract will be open to public viewing. Submit your abstract ...
Presenting Author: Aftab Ala, MBBS, M.D., FRCP, Ph.D. The abstract is currently available on the conference website, and the materials for the oral presentation will be available at www.monopartx.com ...
Nektar Therapeutics (Nasdaq: NKTR) announced today that new data from the ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback